Peptides are rapidly gaining attention across obesity care, wellness, and longevity medicine. Learn what community pharmacists should know about FDA-approved therapies, emerging compounds, safety considerations, and evolving opportunities.
Help your pharmacy make the most of August with health awareness campaigns focused on immunizations, breastfeeding support, and psoriasis awareness. Discover patient education ideas, marketing inspiration, and practical ways to engage your community through timely preventive care initiatives.
The new Medicare GLP-1 Bridge Demonstration Program expands access to select GLP-1 medications for eligible Medicare beneficiaries through the end of 2027. Learn what community pharmacies need to know about covered medications, patient eligibility, claims processing, workflow changes, and how to prepare staff to support patients navigating this new CMS program.
The second quarter of 2026 continued a busy year for the FDA, with notable new drug approvals, expanded indications, and key regulatory decisions that will impact patient care. For community pharmacies, these updates go beyond adding new medications to the shelf—they influence patient counseling, formulary and reimbursement considerations, inventory planning, and clinical decision-making. Staying informed on these developments helps pharmacy teams deliver timely, evidence-based care while preparing for changing patient needs.